Abstract
In an effort to develop a quantitative ligand-binding model for the CB1R, pharmacophore modelling studies were performed on 1-sulfonyl 4-acylpiperazine derivatives. Pharmacophore Alignment and Scoring Engine (PHASE) was used to develop predictive Common Pharmacophore Hypotheses (CPHs) in which a five point pharmacophore with one hydrogen bond acceptor (A), two lipophilic/hydrophobic groups (H) and two aromatic rings (R) as pharmacophoric features was developed. On the basis of statistical values, the best-fitted model was identified and the same alignment was used for CoMFA and CoMSIA studies. The models developed showed an excellent r2 predictive value of 0.879 for CoMFA and 0.764 for CoMSIA. The robustness of the models was validated and the mean activity for test set compounds can estimate external predictivity. The 3D contour maps generated from CoMFA/CoMSIA offer important structural insights and provided interpretable explanation of SAR for the compounds. The obtained results may help in designing analogs with better activity.
Keywords: CB1R, CoMFA, CoMSIA, 3D-QSAR, Endocannabinoid, Obesity, PHASE, ligand-binding model, pharmacophoric features, 3D contour maps, endocannabinoid system, anti-obesity therapeutics, metabolic homeostasis, cannabinoid CB1 inverse agonists, 1-sulfonyl-4-acylpiperazines, 3D-pharmacophore model, GPCR ligand binding modes
Letters in Drug Design & Discovery
Title: Pharmacophore and 3D-QSAR Studies on 1-Sulfonyl-4-acylpiperazines as Selective Cannabinoid-1 Receptor (CB1R) Inverse Agonists
Volume: 8 Issue: 7
Author(s): Vikas N. Telvekar, Lalit B. Thakur, Prashant B. Jagdhane and Yogesh D. Manohar
Affiliation:
Keywords: CB1R, CoMFA, CoMSIA, 3D-QSAR, Endocannabinoid, Obesity, PHASE, ligand-binding model, pharmacophoric features, 3D contour maps, endocannabinoid system, anti-obesity therapeutics, metabolic homeostasis, cannabinoid CB1 inverse agonists, 1-sulfonyl-4-acylpiperazines, 3D-pharmacophore model, GPCR ligand binding modes
Abstract: In an effort to develop a quantitative ligand-binding model for the CB1R, pharmacophore modelling studies were performed on 1-sulfonyl 4-acylpiperazine derivatives. Pharmacophore Alignment and Scoring Engine (PHASE) was used to develop predictive Common Pharmacophore Hypotheses (CPHs) in which a five point pharmacophore with one hydrogen bond acceptor (A), two lipophilic/hydrophobic groups (H) and two aromatic rings (R) as pharmacophoric features was developed. On the basis of statistical values, the best-fitted model was identified and the same alignment was used for CoMFA and CoMSIA studies. The models developed showed an excellent r2 predictive value of 0.879 for CoMFA and 0.764 for CoMSIA. The robustness of the models was validated and the mean activity for test set compounds can estimate external predictivity. The 3D contour maps generated from CoMFA/CoMSIA offer important structural insights and provided interpretable explanation of SAR for the compounds. The obtained results may help in designing analogs with better activity.
Export Options
About this article
Cite this article as:
N. Telvekar Vikas, B. Thakur Lalit, B. Jagdhane Prashant and D. Manohar Yogesh, Pharmacophore and 3D-QSAR Studies on 1-Sulfonyl-4-acylpiperazines as Selective Cannabinoid-1 Receptor (CB1R) Inverse Agonists, Letters in Drug Design & Discovery 2011; 8 (7) . https://dx.doi.org/10.2174/157018011796235284
DOI https://dx.doi.org/10.2174/157018011796235284 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
From Biomarkers to Cytokine-like Hormones: Uncovering New Directives for Cognitive Loss and Alzheimer’s Disease
Current Neurovascular Research PPARγ Agonistic Activity of Sulphonylureas
Endocrine, Metabolic & Immune Disorders - Drug Targets Health Information Technology and Diabetes Management: A Review of Motivational and Inhibitory Factors
Current Diabetes Reviews Can we Consider Zoledronic Acid a New Antitumor Agent? Recent Evidence in Clinical Setting
Current Cancer Drug Targets Studies on Structures and Functions of Kinases leading to Prostate Cancer and Their Inhibitors
Current Enzyme Inhibition Xenobiotic Metabolising Enzymes: Impact on Pathologic Conditions, Drug Interactions and Drug Design
Current Topics in Medicinal Chemistry Tetracyclic Triterpenoids in Herbal Medicines and their Activities in Diabetes and its Complications
Current Topics in Medicinal Chemistry Chemistry and Biology of Indoles and Indazoles: A Mini-Review
Mini-Reviews in Medicinal Chemistry The Role of Endostatin in Rheumatoid Arthritis
Current Rheumatology Reviews MRI findings and renal function in patients on lithium therapy
Current Drug Safety Cancer and Phase II Drug-Metabolizing Enzymes
Current Drug Metabolism Bioartificial Pancreas: Drug Delivery through Islet Microencapsulation to Treat Diabetes
Recent Patents on Biomedical Engineering (Discontinued) Stage B: What is the Evidence for Treatment of Asymptomatic Left Ventricular Dysfunction?
Current Cardiology Reviews Lipid Behavior in Metabolic Syndrome Pathophysiology
Current Diabetes Reviews Why is the Inhibition of the Renin-Angiotensin System Effective for Preventing Cardiac Events in Patients with Coronary Risk Factors or Coronary Artery Disease?
Current Cardiology Reviews Bowel Habit in Preterm New borns: Effect of New Formulas
Endocrine, Metabolic & Immune Disorders - Drug Targets Caffeine Effect on HIFs/VEGF Pathway in Human Glioblastoma Cells Exposed to Hypoxia
Anti-Cancer Agents in Medicinal Chemistry Nuclear Hormone Receptor Signals as New Therapeutic Targets for Urothelial Carcinoma
Current Cancer Drug Targets Inhibitors of HIV-1 Protease: Current State of the Art 10 Years After their Introduction. From Antiretroviral Drugs to Antifungal, Antibacterial and Antitumor Agents Based on Aspartic Protease Inhibitors
Current Medicinal Chemistry Pathogenesis of Diabetic Retinopathy and Diabetic Macular Edema and Enzyme Inhibition
Current Enzyme Inhibition